ADHD medication shows promise for amphetamine addiction
Compared to other experimental therapies, treatment with the ADHD medication lisdexamfetamine resulted in the lowest risk of hospitalization and death among people with amphetamine addiction, researchers reported on Nov. 16, 2022 in JAMA Psychiatry. ”Our results suggest that lisdexamfetamine is associated with the best outcomes, and encourage the conduction of randomized controlled trials to explore this further,” said investigator Jari […]
Recent Comments